RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Cash and cash equivalents

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Jun 30, 20251,209+407.40%
Jun 30, 2024238+4.59%
Jun 30, 2023228-16.74%
Jun 30, 2022274-7.30%
Jun 30, 2021295-36.25%
Jun 30, 2020463+214.80%
Jun 30, 2019147-22.03%
Jun 30, 2018189-77.04%
Jun 30, 2017822+12.37%
Jun 30, 2016731+1.98%
Jun 30, 2015717-20.81%
Jun 30, 2014906+3.39%
Jun 30, 2013876+8.22%
Jun 30, 2012810+10.10%
Jun 30, 2011735

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)